ADAM10 Sheddase Activity is a Potential Lung-Cancer Biomarker
Background: Increases in expression of ADAM10 and ADAM17 genes and proteins are inconsistently found in cancer lesions, and are not validated as clinically useful biomarkers. The enzyme-specific proteolytic activities, which are solely mediated by the active mature enzymes, directly reflect enzyme c...
Main Authors: | Yoneyama, Toshie, Gorry, Michael, Sobo-Vujanovic, Andrea, Lin, Yan, Vujanovic, Lazar, Gaither-Davis, Autumn, Moss, Marcia L., Stabile, Laura P., Herman, James, Vujanovic, Nikola L., Miller, Miles Aaron, Griffith, Linda G, Lauffenburger, Douglas A |
---|---|
Other Authors: | Massachusetts Institute of Technology. Biotechnology Process Engineering Center |
Format: | Article |
Published: |
Ivyspring International Publisher
2018
|
Online Access: | http://hdl.handle.net/1721.1/117640 https://orcid.org/0000-0002-1801-5548 https://orcid.org/0000-0002-0050-989X |
Similar Items
-
Modification of proteolytic activity matrix analysis (PrAMA) to measure ADAM10 and ADAM17 sheddase activities in cell and tissue lysates
by: Yoneyama, Toshie, et al.
Published: (2018) -
Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain
by: Miller, Miles Aaron, et al.
Published: (2015) -
Understanding and targeting network-level sheddase regulation in invasive disease
by: Miller, Miles Aaron
Published: (2013) -
FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex
by: Kuenzel, U, et al.
Published: (2018) -
ADAM9 inhibition increases membrane activity of ADAM10 and controls α-secretase processing of amyloid precursor protein
by: Moss, Marcia L., et al.
Published: (2013)